Usfda
- All
- News
- Videos
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Synchron Switch Now Lets You Control Your iPhone or iPad Using Brain: All Details
Brain chip implant developer Synchron has created a device called 'Synchron Switch' that allows patients to control an iPhone or iPad using their brain. Synchron’s technology could lead to major advances and would change the day-to-day lives of people with severe disabilities.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
The USFDA has determined that the inspection classification of the facility is VAI, the company said in a statement.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Biocon Recalls 3,665 Bottles Of Antifungal Drug In US For "Failed Specifications"
Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications", according to the US Food and Drug Administration (USFDA).
-
Starbucks Vanilla Frappuccino Bottles In US Recalled Over Health Safety Concerns
The US Food and Drug Administration said that more than 25,000 cases of the glass bottles have been recalled.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Zydus Gets US Regulator's Approval To Market Generic Epilepsy Drug
The drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, Zydus said in a statement.
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Synchron Switch Now Lets You Control Your iPhone or iPad Using Brain: All Details
Brain chip implant developer Synchron has created a device called 'Synchron Switch' that allows patients to control an iPhone or iPad using their brain. Synchron’s technology could lead to major advances and would change the day-to-day lives of people with severe disabilities.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
The USFDA has determined that the inspection classification of the facility is VAI, the company said in a statement.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
